Ferroptosis Target Information
General Information of the Ferroptosis Target (ID: TAR10061)
Target Name | Voltage-dependent anion-selective channel protein 2 (VDAC2) | ||||
---|---|---|---|---|---|
Synonyms |
Outer mitochondrial membrane protein porin 2
Click to Show/Hide
|
||||
Gene Name | VDAC2 | ||||
Sequence |
MATHGQTCARPMCIPPSYADLGKAARDIFNKGFGFGLVKLDVKTKSCSGVEFSTSGSSNT
DTGKVTGTLETKYKWCEYGLTFTEKWNTDNTLGTEIAIEDQICQGLKLTFDTTFSPNTGK KSGKIKSSYKRECINLGCDVDFDFAGPAIHGSAVFGYEGWLAGYQMTFDSAKSKLTRNNF AVGYRTGDFQLHTNVNDGTEFGGSIYQKVCEDLDTSVNLAWTSGTNCTRFGIAAKYQLDP TASISAKVNNSSLIGVGYTQTLRPGVKLTLSALVDGKSINAGGHKVGLALELEA Click to Show/Hide
|
||||
Family | Eukaryotic mitochondrial porin family | ||||
Function |
Forms a channel through the mitochondrial outer membrane that allows diffusion of small hydrophilic molecules. The channel adopts an open conformation at low or zero membrane potential and a closed conformation at potentials above 30-40 mV. The open state has a weak anion selectivity whereas the closed state is cation-selective. Binds various lipids, including the sphingolipid ceramide, the phospholipid phosphatidylcholine, and the sterol cholesterol. Binding of ceramide promotes the mitochondrial outer membrane permeabilization (MOMP) apoptotic pathway.
Click to Show/Hide
|
||||
Gene ID | 7417 | ||||
Uniprot ID | |||||
Target Type | Driver Suppressor Marker | ||||
Mechanism Diagram | Click to View the Original Diagram | ||||
![]() |
Full List of Regulator(s) of This Ferroptosis Target and Corresponding Disease/Drug Response(s)
VDAC2 can be involved in and affect the ferroptosis by the following regulators, and result in corresponding disease/drug response(s). You can browse corresponding disease or drug response(s) resulting from the regulation of certain regulators.
Browse Regulator related Disease
Browse Regulator related Drug
E3 ubiquitin-protein ligase NEDD4 (NEDD4)
Breast cancer [ICD-11: 2C60]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the Ferroptosis-centered Disease Response of This Regulator | [1] | |||
Regulator for Ferroptosis | Suppressor | |||
Responsed Drug | Robustaflavone | Investigative | ||
Pathway Response | Ferroptosis | hsa04216 | ||
Cell Process | Cell ferroptosis | |||
Cell proliferation | ||||
In Vitro Model |
MCF-7 cells | Breast carcinoma | Homo sapiens | CVCL_0031 |
Response Description | Robustaflavone A strikingly induced MCF-7 nonapoptotic cell death through ferroptosis by enhancing the expression of VDAC2 channels and reducing the expression of Nedd4 E3 ubiquitin ligase, leading to lipid peroxidation and ROS production. The results suggested that RF-A has potential as a novel breast cancer treatment through its regulation of the mitochondrial VDAC2 and Nedd4 pathways. | |||
Melanoma [ICD-11: 2C30]
In total 1 item(s) under this disease | |||||
Experiment 1 Reporting the Ferroptosis-centered Disease Response of This Regulator | [2] | ||||
Regulator for Ferroptosis | Suppressor | ||||
Pathway Response | Fatty acid metabolism | hsa01212 | |||
Ferroptosis | hsa04216 | ||||
Ubiquitin mediated proteolysis | hsa04120 | ||||
Cell Process | Cell ferroptosis | ||||
Cell proliferation | |||||
In Vitro Model |
A-375 cells | Amelanotic melanoma | Homo sapiens | CVCL_0132 | |
G-361 cells | Melanoma | Homo sapiens | CVCL_1220 | ||
MeWo cells | Melanoma | Homo sapiens | CVCL_0445 | ||
SK-MEL-2 cells (MEK inhibitor-resistant) cells | Melanoma | Homo sapiens | CVCL_0069 | ||
SK-MEL-3 cells | Cutaneous melanoma | Homo sapiens | CVCL_0550 | ||
SK-MEL-24 cells | Melanoma | Homo sapiens | CVCL_0599 | ||
WM2032 cells | Melanoma | Homo sapiens | CVCL_0B68 | ||
HEK-293T cells | Normal | Homo sapiens | CVCL_0063 | ||
In Vivo Model |
NU/NU Nude mice were purchased from Charles River (Beijing). To generate murine subcutaneous tumors, melanoma cells (5 x 106 cells per mouse) were injected subcutaneously into the left posterior flanks of 7-week-old immunodeficient female nude mice.
Click to Show/Hide
|
||||
Response Description | Knockdown of Nedd4 leads to elevated protein level of VDAC2/3, which increased the sensitivity of melanoma cells to erastin both in vitro and in vivo. | ||||
E3 ubiquitin-protein ligase NEDD4 (NEDD4)
Robustaflavone
[Investigative]
In total 1 item(s) under this drug | ||||
Experiment 1 Reporting the Ferroptosis-centered Drug Response of This Regulator | [1] | |||
Regulator for Ferroptosis | Suppressor | |||
Responsed Disease | Breast cancer [ICD-11: 2C60] | |||
Pathway Response | Ferroptosis | hsa04216 | ||
Cell Process | Cell ferroptosis | |||
Cell proliferation | ||||
In Vitro Model | MCF-7 cells | Breast carcinoma | Homo sapiens | CVCL_0031 |
Response Description | Robustaflavone A strikingly induced MCF-7 nonapoptotic cell death through ferroptosis by enhancing the expression of VDAC2 channels and reducing the expression of Nedd4 E3 ubiquitin ligase, leading to lipid peroxidation and ROS production. The results suggested that RF-A has potential as a novel breast cancer treatment through its regulation of the mitochondrial VDAC2 and Nedd4 pathways. | |||
References